摘要
实验和计算放映是目前广泛的工具,用于确定一个给定的化学化合物任一潜在的配体的一个给定的目标或潜在的目标。特别是,对热变性(或热转移法)配体诱导的稳定是一种简单方便的找到的化合物能够控制一个靶蛋白活性的实验程序(例如,变构或竞争性抑制剂干预其活动,变构激活剂增强它的活性,或药物分子伴侣避免聚集,展开或降解)。尽管它的简单的热转移分析有一些重要的缺点。在这里,我们描述了这种方法在结构和非结构蛋白的目标中的应用,并讨论了对损失的功能相关的构象疾病的生物活性化合物的鉴定成功案例(苯丙酮尿症)和传染病(胃溃疡和丙型肝炎)。
关键词: 变构和竞争性抑制剂构象病,实验分子筛选,荧光热转移,传染病,配体诱导的稳定,药物分子伴侣蛋白的稳定性。
图形摘要
Current Drug Targets
Title:Biophysical Screening for Identifying Pharmacological Chaperones and Inhibitors Against Conformational and Infectious Diseases
Volume: 17 Issue: 13
Author(s): Adrián Velazquez-Campoy, Javier Sancho, Olga Abian, Sonia Vega
Affiliation:
关键词: 变构和竞争性抑制剂构象病,实验分子筛选,荧光热转移,传染病,配体诱导的稳定,药物分子伴侣蛋白的稳定性。
摘要: Experimental and computational screenings are currently widespread tools for identifying either potential ligands for a given target or potential targets for a given chemical compound. In particular, ligand-induced stabilization against thermal denaturation (or thermal shift assay) is an easy and convenient experimental procedure for finding compounds able to control the activity of a protein target (e.g., allosteric or competitive inhibitors interfering with its activity, allosteric activators enhancing its activity, or pharmacological chaperones avoiding aggregation, unfolding or degradation). Despite its simplicity the thermal shift assay does not lack some important drawbacks. Here we describe this methodology, its application to structured and unstructured protein targets, and we discuss successful cases of identification of bioactive compounds for conformational disorders associated to loss of function (phenylketonuria) and infectious diseases (gastric ulcer and hepatitis C).
Export Options
About this article
Cite this article as:
Adrián Velazquez-Campoy, Javier Sancho, Olga Abian, Sonia Vega , Biophysical Screening for Identifying Pharmacological Chaperones and Inhibitors Against Conformational and Infectious Diseases, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666160201110449
DOI https://dx.doi.org/10.2174/1389450117666160201110449 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Current Pharmaceutical Design Compounds Containing Azole Scaffolds as Cyclooxygenase Inhibitors: A Review
Current Topics in Medicinal Chemistry Synthesis and Antitumor Evaluation of Thiophene Analogs of Kigelinone
Letters in Organic Chemistry Nanocrystal Approaches for Poorly Soluble Drugs and their Role in Development of Marketed Formulation
Drug Delivery Letters Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
Anti-Cancer Agents in Medicinal Chemistry The Evaluation and Utilization of Marine-derived Bioactive Compounds with Anti-obesity Effect
Current Medicinal Chemistry New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies
Current Medicinal Chemistry Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features
Current Pharmaceutical Design Quinoxalinone as a Privileged Platform in Drug Development
Mini-Reviews in Medicinal Chemistry Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Application of Gene Therapy in Diabetes Care
Infectious Disorders - Drug Targets EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
Current Genomics Predictive Markers for Haematological Toxicity of Pemetrexed
Current Drug Targets The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis
Current Drug Discovery Technologies Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs as Cyclooxygenase Inhibitors: State of the Art, Barriers and Perspectives
Current Computer-Aided Drug Design Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells
Recent Patents on Anti-Cancer Drug Discovery Matrine: Bioactivities and Structural Modifications
Current Topics in Medicinal Chemistry